FDA is calling for Congress to set up a new regulatory pathway for cannabidiol (CBD) products after concluding the current framework for foods and dietary supplements won’t work for CBD, nor is it appropriate for animal food. FDA on Thursday (Jan. 26) said a regulatory pathway for CBD needs to ensure individuals can access the products while also providing regulatory oversight to manage the risks. The use of CBD, especially long-term use, raises safety concerns, FDA Principal Deputy Commissioner Janet...